{
  "Q0": "Mitochondrial DNA panel (multi-gene targeted panel testing for mitochondrial disease).",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4.1": "Yes",
  "Q4.2": "None of the above",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Not specified",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Not specified",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14.1": "81460, 81465, 0417U",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "To submit the claim, ensure that the test was ordered by or in consultation with a board-certified medical geneticist or neurologist, and that documentation supports a high degree of suspicion for mitochondrial disease based on clinical features (progressive external ophthalmoplegia, sensorineural hearing loss, exercise-induced fatigue). Include relevant CPT code(s) (e.g., 81460, 81465, 0417U) and submit all required clinical documentation as outlined in the policy. Confirm that the member\u2019s specific benefit plan does not have additional requirements or exclusions.",
  "match": true
}